Vanguard Asset Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Vanguard Asset Management's ROIV Position: Q3 2026 in Review
Vanguard Asset Management reduced its Roivant Sciences (ROIV) stake by 34% in Q3 2026, selling an estimated $5.49M and leaving 299,031 shares worth $10.9M. The position accounts for 0.01% of the portfolio, ranked #679.
Vanguard Asset Management first reported a position in ROIV in Q1 2026 and has held it in 3 quarters since. The position peaked at $15.9M in Q2 2026. 462 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Vanguard Asset Management held 299,031 shares of Roivant Sciences worth $10.9M as of Q3 2026.
- Vanguard Asset Management sold 151,296 Roivant Sciences shares in Q3 2026, an estimated $5.49M.
- Roivant Sciences made up 0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #679 holding.
- Vanguard Asset Management first reported a position in Roivant Sciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Asset Management's Roivant Sciences position peaked at $15.9M in Q2 2026.
- 462 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.